The STT3A gene helps cells attach small sugar tags to newly made proteins, a step that helps many proteins fold, move to the right place, and work properly. If STT3A is not working well, many proteins can be made incorrectly, which may affect several organs, especially the brain, muscles, and digestive system. Pathogenic variants in the STT3A gene are linked to a rare inherited condition that can cause developmental delay, low muscle tone, feeding problems, and seizures. STT3A is mainly known in medical genetics rather than in popular culture.
What is a gene?
Genes are sections of DNA that give your cells instructions to make molecules or manage activities in the body. Some genes carry the directions for building proteins, which do much of the cell’s work. Other genes mainly regulate when certain activities take place, where they occur, and how strongly they run. Together, genes affect how the body develops and works, and they may influence how you respond to food, stress, and medicines. To explore this topic in more detail, you can find more in the LearnHub.
Overview
STT3AGene function
What if the gene works
The STT3A gene helps cells add sugar tags to many newly made proteins in the endoplasmic reticulum, a cell compartment that folds proteins. These tags help proteins fold properly, stay stable, and reach the right place.
Risk
What if the gene does not work
More severe variants in the STT3A gene can cause a congenital glycosylation condition with developmental delay, low muscle tone, feeding problems, and seizures. Milder variants may cause a less severe pattern, with symptoms starting later.
Treatment
What does that mean for your treatment
No STT3A-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the STT3A gene. Treatment is guided by the person’s symptoms and routine supportive care, not by a drug choice linked specifically to STT3A.
Conditions associated with STT3A
Gene function
What if the gene works
Many proteins need a small sugar tag before they can fold, travel, and work the right way. The STT3A gene helps cells add this tag while new proteins are being built in the endoplasmic reticulum, the cell area that processes proteins. This is a key part of what the STT3A gene does in the body.
The STT3A gene helps cells attach sugar chains to many newly made proteins. This process, called glycosylation (adding sugar groups), is a normal early step in protein preparation.
It works while proteins are still being built and entering the endoplasmic reticulum, the cell area that processes proteins. That timing lets cells modify proteins at a very early stage.
These sugar tags help many proteins fold into a stable shape. They also support routine quality checks before proteins move to where the cell needs them.
Its protein works with a larger cell team to place sugar chains at the right spots. This helps many proteins become ready for transport and everyday cell tasks.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants influence the STT3A gene's function usually comes down to how much they weaken glycosylation (the step that adds sugar chains to newly made proteins). Some variants mainly lower STT3A protein stability or activity, while more disruptive variants can interfere with assembly of the cell machinery that carries out this process and leave many proteins incompletely processed. This range of effects can help explain why STT3A-related congenital disorders of glycosylation may appear earlier or be more pronounced in some people than in others.
How variants are linked to conditions
Pathogenic variants in the STT3A gene cause STT3A-congenital disorder of glycosylation, a rare inherited condition. People with this diagnosis often have developmental delay, low muscle tone, feeding problems, seizures, and sometimes vision or coordination difficulties. In practice, variants in the STT3A gene linked to congenital disorder of glycosylation can confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a normal part of human biology and are common across the general population. Most do not directly affect health and instead reflect the natural range of human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the STT3A gene. For families with a harmful change in STT3A, risk is mainly shaped by whether that change is inherited rather than by lifestyle or everyday exposures.
Inheritance of STT3A variants
STT3A-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one STT3A variant from each parent, while parents who carry one variant typically do not have the condition themselves. When both parents carry a variant in the STT3A gene, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a carrier child, and a 25% chance of inheriting neither variant. This is the usual pattern doctors mean when they explain how STT3A variants are inherited.
What does my STT3A result mean for my family?
Changes in the STT3A gene linked to disease are inherited in a recessive pattern, so family members are usually affected only if they inherited two changed copies. For relatives, this often means parents are healthy carriers, and brothers or sisters may also be carriers or, less often, have the condition. Other close relatives may also carry the gene change, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the STT3A gene, doctors use genetic testing for STT3A variants, usually from a blood sample or saliva. A lab reads the DNA code in the STT3A gene and compares it with the usual sequence to identify variants, which may then be classified by their likely health effect.
When should I consider getting a genetic test?
Testing may be worth discussing if a child has unexplained developmental delay, low muscle tone, seizures, feeding problems, or slow growth, especially if more than one family member is affected. STT3A changes are a known cause of a rare inherited condition present from birth.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it can tell you varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, cause more side effects in another, or seem less effective in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. By looking at links between genes and drugs, it helps explain why treatments can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the STT3A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so general questions about side effects, new symptoms, or how a treatment is working are best discussed with your doctor.